- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Telemedicine ‘Blueprint’ Introduced to Assess and Triage Patients With COVID-19
Video doctor visits limit spread of disease, help determine health risks to patients.
While people with coronavirus disease 2019 (COVID-19) who are in acute distress may need immediate in-person attention, many people can be evaluated at home through video doctor visits, thereby maintaining social distancing and reducing the spread of the disease. Limited guidance exists, however, for the remote delivery of healthcare, though the need has risen significantly during the pandemic. Now medical experts affiliated with NYU Long Island School of Medicine and NYU Langone Health have collaborated to develop a template for remote COVID-19 healthcare delivery, including protocols for assessing and triaging patients who may test positive for COVID-19.
The spectrum of symptoms in people infected with COVID-19 range from asymptomatic to severe and life-threatening; the more benign manifestations are often able to be managed from home. A new report, titled “A Telemedicine Approach to Covid-19 Assessment and Triage,” published on September 9, 2020, in Medicina, a peer-reviewed scientific and medical journal, outlines protocols for assessing various patient symptoms through virtual means.
The paper notes that these protocols are most easily applicable in settings that have adequate internet or phone connections, and that, when the technology is available, telemedicine is also promising for delivery of care to persons living in remote areas where distance is a barrier to seeking help.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
